How We’re Mobilizing Our Resources to Help Find Solutions for COVID-19
Learn More
Share
Global Disease Challenges
hile the world continues to face ongoing challenges with HIV and tuberculosis, and many unknown and emerging threats, there is also an increasing shift in burden of disease toward noncommunicable diseases (NCDs) and mental health. At Johnson & Johnson, we are passionate about our work to save and improve people’s lives. We forge partnerships and identify new ways to pioneer human ingenuity to accelerate the development of new drug regimens, support the strengthening of healthcare systems and break down barriers to access in resource-limited settings.
Our Aspiration: A world where innovations and holistic health solutions prevent, control and eliminate global disease challenges and epidemics.
5-Year Target: 175 million individuals will have benefited from Johnson & Johnson solutions that prevent, control and eliminate global diseases.
Status: Exceeded
Our Impact:
• How Johnson & Johnson Is Helping Tackle a Devastating Tropical Disease That Impacts Kids
• Working to Make HIV History
Related Content
Johnson & Johnson has signed up to the 2030 UN Sustainable Development Goals—the world’s road map for progress.
More From Johnson & Johnson
A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19. We share more about the findings from the recent preclinical study, along with other up-to-date information about the potential vaccine candidate.
On the latest episode of "The Road to a Vaccine," host Lisa Ling delves into the effects of the pandemic on kids. We sat down with one of the guests, Vikram Patel, a professor at Harvard Medical School, to find out the most pressing questions on his mind.
Think you are up to speed on the novel coronavirus? Take this quiz to test your virus knowledge.
